Top Markets
Coin of the day
Agentix Corp. Agentix Corp.

Agentix Corp.

AGTX
株式のランク #38794
Agentix Corp., a company in the clinical development phase, specializes in the... Agentix Corp., a company in the clinical development phase, specializes in the discovery and commercialization of therapeutic agents aimed at treating metabolic disorders. Its pipeline includes two primary candidates: AGTX-2004, a peripherally-acting CB1 receptor antagonist, which has exhibited effectiveness in animal studies for both obesity and type 2 diabetes mellitus; and AGTX-2003, a peripherally-acting CB1 receptor inverse agonist, also demonstrating positive results in animal models for obesity and non-alcoholic fatty liver diseases. The company was founded in 2013, initially known as FairWind Energy, Inc., before officially changing its name to Agentix Corp. in June 2019. Its operations are based in Dana Point, California.
株価
$0.02
最終同期: 2026-08-13
時価総額
$801.34K
変化(1日)
0.00%
変化(1年)
-18.70%
US
取引 Agentix Corp. (AGTX)

カテゴリー

Agentix Corp.(AGTX)の配当利回りの履歴
Agentix Corp.(銘柄コード: AGTX)の配当利回り(TTM)は2026時点で0です。
過去5年間の平均配当利回り: 0.00%
Agentix Corp.(AGTX)の2026から2026までの配当利回りの履歴
各年末時点の配当利回り(TTM)
配当利回り 変化
提供された日付のデータは十分ではありません。
類似企業または競合他社の配当利回り(TTM)